Last reviewed · How we verify

Sepia 30C — Competitive Intelligence Brief

Sepia 30C (Sepia 30C) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

Sepia 30C (Sepia 30C) — Shaare Zedek Medical Center. Sepia 30C is a homeopathic remedy derived from cuttlefish ink, used in traditional homeopathic medicine based on the principle of treating symptoms with highly diluted substances.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sepia 30C TARGET Sepia 30C Shaare Zedek Medical Center marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sepia 30C — Competitive Intelligence Brief. https://druglandscape.com/ci/sepia-30c. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: